Lv6
2450 积分 2022-11-10 加入
Berberine prevents NAFLD and HCC by modulating metabolic disorders
1天前
已完结
Real-world individual and comparative analysis of adverse event reporting for adalimumab and etanercept using public FDA adverse event reporting system data
3天前
已完结
Safety evaluation of ILaris: a real-world analysis of adverse events based on the FAERS Database
3天前
已完结
BCMA-CAR T-cells in a patient with relapsing idiopathic inflammatory myositis after CD19-CAR T-cells
4天前
已完结
Interleukin 6 as an energy allocator in muscle tissue
5天前
已完结
Inflammation and resolution in obesity
5天前
已完结
Inflammation and resolution in obesity
20天前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
Rare oncology therapeutics: review of clinical pharmacology package of drug approvals (2019–2023) by US FDA, best practices and recommendations
1个月前
已完结
Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers
1个月前
已完结
Surface electron doping induced double gap opening in T d-WTe2
皖公网安备34019202002308
